D
BioRestorative Therapies, Inc.
BRTX
$1.79
$0.0553.17%
D
Sell
10/23/2024Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 10/23/2024 due to an increase in the volatility index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 10/23/2024 due to an increase in the volatility index.
E
Sell
10/8/2024Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 10/8/2024 due to a decline in the volatility index, total return index and valuation index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 10/8/2024 due to a decline in the volatility index, total return index and valuation index.
D
Sell
8/16/2024Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 8/16/2024 due to a major increase in the growth index and volatility index. Total revenue increased 154.57% from $35 to $89.1, EBIT increased 39.92% from -$4.11M to -$2.47M, and operating cash flow increased 19.53% from -$2.32M to -$1.87M.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 8/16/2024 due to a major increase in the growth index and volatility index. Total revenue increased 154.57% from $35 to $89.1, EBIT increased 39.92% from -$4.11M to -$2.47M, and operating cash flow increased 19.53% from -$2.32M to -$1.87M.
E
Sell
8/5/2024Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 8/5/2024 due to a decline in the volatility index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 8/5/2024 due to a decline in the volatility index.
D
Sell
7/19/2024Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 7/19/2024 due to an increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.02 to 0.01, and the quick ratio increased from 4.25 to 4.77.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 7/19/2024 due to an increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.02 to 0.01, and the quick ratio increased from 4.25 to 4.77.
E
Sell
5/29/2024Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 5/29/2024 due to a decline in the total return index and volatility index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 5/29/2024 due to a decline in the total return index and volatility index.
D
Sell
5/14/2024Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 5/14/2024 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.64 to -$0.6056.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 5/14/2024 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.64 to -$0.6056.
E
Sell
9/15/2023Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 9/15/2023 due to a decline in the total return index and volatility index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 9/15/2023 due to a decline in the total return index and volatility index.
D
Sell
8/31/2023Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 8/31/2023 due to an increase in the volatility index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D- from E+ on 8/31/2023 due to an increase in the volatility index.
E
Sell
8/16/2023Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 8/16/2023 due to a decline in the volatility index, solvency index and valuation index. The quick ratio declined from 26.34 to 14.32.
BioRestorative Therapies, Inc. (BRTX) was downgraded to E+ from D- on 8/16/2023 due to a decline in the volatility index, solvency index and valuation index. The quick ratio declined from 26.34 to 14.32.
D
Sell
3/14/2023Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 03/14/2023.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 2/8/2023 due to a large decline in the total return index and solvency index. The quick ratio declined from 28.87 to 23.05.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 2/8/2023 due to a large decline in the total return index and solvency index. The quick ratio declined from 28.87 to 23.05.
D
Sell
5/4/2022Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 5/4/2022 due to a noticeable increase in the total return index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 5/4/2022 due to a noticeable increase in the total return index.
D
Sell
4/18/2022Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 4/18/2022 due to a large decline in the growth index. Operating cash flow declined 81.92% from -$629.4 to -$1.15M, earnings per share declined from -$4.989 to -$8.5538, and total revenue declined 37.5% from $8 to $5.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 4/18/2022 due to a large decline in the growth index. Operating cash flow declined 81.92% from -$629.4 to -$1.15M, earnings per share declined from -$4.989 to -$8.5538, and total revenue declined 37.5% from $8 to $5.
D
Sell
11/18/2021Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 11/18/2021 due to an increase in the solvency index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 11/18/2021 due to an increase in the solvency index.
D
Sell
11/8/2021Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the valuation index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the valuation index.
D
Sell
8/9/2021Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 8/9/2021 due to a substantial increase in the valuation index and volatility index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D from D- on 8/9/2021 due to a substantial increase in the valuation index and volatility index.
D
Sell
7/1/2021Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 7/1/2021 due to a substantial decline in the valuation index and growth index. EBIT declined 1,661.81% from -$854.5 to -$15.05M, earnings per share declined from -$0.0027 to -$0.01, and operating cash flow declined 42.23% from -$572.1 to -$813.7.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D- from D on 7/1/2021 due to a substantial decline in the valuation index and growth index. EBIT declined 1,661.81% from -$854.5 to -$15.05M, earnings per share declined from -$0.0027 to -$0.01, and operating cash flow declined 42.23% from -$572.1 to -$813.7.
D
Sell
8/3/2020Upgraded
BioRestorative Therapies, Inc. (BRTXQ) was upgraded to D from D- on 8/3/2020 due to an increase in the volatility index and total return index.
BioRestorative Therapies, Inc. (BRTXQ) was upgraded to D from D- on 8/3/2020 due to an increase in the volatility index and total return index.
D
Sell
7/14/2020Downgrade
BioRestorative Therapies, Inc. (BRTXQ) was downgraded to D- from D on 7/14/2020 due to a decline in the volatility index.
BioRestorative Therapies, Inc. (BRTXQ) was downgraded to D- from D on 7/14/2020 due to a decline in the volatility index.
D
Sell
6/26/2020Upgraded
BioRestorative Therapies, Inc. (BRTXQ) was upgraded to D from D- on 6/26/2020 due to an increase in the volatility index and total return index.
BioRestorative Therapies, Inc. (BRTXQ) was upgraded to D from D- on 6/26/2020 due to an increase in the volatility index and total return index.
D
Sell
5/1/2020Downgrade
BioRestorative Therapies, Inc. (BRTXQ) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. The quick ratio declined from 0.12 to 0.01, total capital declined 46.35% from -$3.24M to -$4.75M, and net income declined 21.64% from -$4.16M to -$5.06M.
BioRestorative Therapies, Inc. (BRTXQ) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. The quick ratio declined from 0.12 to 0.01, total capital declined 46.35% from -$3.24M to -$4.75M, and net income declined 21.64% from -$4.16M to -$5.06M.
D
Sell
11/14/2018Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D from D+ on 11/14/2018 due to a noticeable decline in the total return index, volatility index and solvency index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D from D+ on 11/14/2018 due to a noticeable decline in the total return index, volatility index and solvency index.
D
Sell
1/16/2018Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 1/16/2018 due to a decline in the total return index.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 1/16/2018 due to a decline in the total return index.
C
Hold
12/21/2017Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to C- from D+ on 12/21/2017 due to an increase in the volatility index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to C- from D+ on 12/21/2017 due to an increase in the volatility index.
D
Sell
12/5/2017Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 12/5/2017 due to a decline in the total return index and solvency index. The quick ratio declined from 0 to 0, and debt to equity increased from -0.45 to -0.44.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 12/5/2017 due to a decline in the total return index and solvency index. The quick ratio declined from 0 to 0, and debt to equity increased from -0.45 to -0.44.
C
Hold
10/19/2017Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to C- from D+ on 10/19/2017 due to an increase in the total return index and growth index. Total revenue increased 185.71% from $7 to $20, operating cash flow increased 37.16% from -$1.22M to -$766, and earnings per share increased from -$0.5588 to -$0.5086.
BioRestorative Therapies, Inc. (BRTX) was upgraded to C- from D+ on 10/19/2017 due to an increase in the total return index and growth index. Total revenue increased 185.71% from $7 to $20, operating cash flow increased 37.16% from -$1.22M to -$766, and earnings per share increased from -$0.5588 to -$0.5086.
D
Sell
6/12/2017Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 6/12/2017 due to a decline in the growth index and solvency index. The quick ratio declined from 0.01 to 0, EBIT declined 32.99% from -$1.87M to -$2.49M, and earnings per share declined from -$0.4486 to -$0.5588.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 6/12/2017 due to a decline in the growth index and solvency index. The quick ratio declined from 0.01 to 0, EBIT declined 32.99% from -$1.87M to -$2.49M, and earnings per share declined from -$0.4486 to -$0.5588.
C
Hold
3/3/2017Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to C- from D+ on 3/3/2017 due to an increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.5637 to -$0.4282, and EBIT increased 19.97% from -$2.14M to -$1.72M.
BioRestorative Therapies, Inc. (BRTX) was upgraded to C- from D+ on 3/3/2017 due to an increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.5637 to -$0.4282, and EBIT increased 19.97% from -$2.14M to -$1.72M.
D
Sell
4/20/2016Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to D+ from D on 4/20/2016 due to an increase in the total return index and volatility index.
BioRestorative Therapies, Inc. (BRTX) was upgraded to D+ from D on 4/20/2016 due to an increase in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index. Total revenue declined 35.42% from $148.8 to $96.1, and EBIT declined 17.98% from -$1.26M to -$1.49M.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index. Total revenue declined 35.42% from $148.8 to $96.1, and EBIT declined 17.98% from -$1.26M to -$1.49M.
C
Hold
11/14/2014Upgraded
BioRestorative Therapies, Inc. (BRTX) was upgraded to C from D+ on 11/14/2014 due to a significant increase in the efficiency index, growth index and solvency index. The quick ratio increased from 0.01 to 0.05.
BioRestorative Therapies, Inc. (BRTX) was upgraded to C from D+ on 11/14/2014 due to a significant increase in the efficiency index, growth index and solvency index. The quick ratio increased from 0.01 to 0.05.
D
Sell
8/15/2014Downgrade
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 8/15/2014 due to a significant decline in the efficiency index, solvency index and total return index. The quick ratio declined from 0.01 to 0.01, total capital declined 23.17% from -$1.52M to -$1.17M, and net income declined 20.16% from -$1.67M to -$1.33M.
BioRestorative Therapies, Inc. (BRTX) was downgraded to D+ from C- on 8/15/2014 due to a significant decline in the efficiency index, solvency index and total return index. The quick ratio declined from 0.01 to 0.01, total capital declined 23.17% from -$1.52M to -$1.17M, and net income declined 20.16% from -$1.67M to -$1.33M.
NASDAQ
04/11/2025 3:59PM Eastern
Quotes delayed
